Biotech Values

[mcbio]

Re: ACHN share movement

ACHN and IDIX - Very subdued reaction which pisses me off since I put more money in ACHN than IDIX. I imagine until the additional cohort data is released in the coming weeks the share price will remain in the low 3's.

There was nothing new at all in the news posted today so there really shouldn't have been a strong reaction to the EASL PR. By contrast, IDIX had very good new news regarding IDX-184 so the big jump comes as no big surprise to me. I would say I'm surprised that ACHN sold off 10% on the news today, but perhaps that's because the news was just a rehash and they had nothing new to report. Perhaps investors were hoping for a partnership announcement or something. I have no clue, but it seems to be an overreaction on the downside IMHO.

As I've said before, I don't know how much the additional Phase 1b cohort data for ACH-1625 will do to move the stock in either direction. Obviously any negative data will move it downward, but I'm not sure if positive data from the QD cohort will be enough to propel the stock materially forward. I really believe it's going to take a lucrative partnership for ACH-1625 to propel the stock materially higher.